通过专为投资者打造的一站式数据看板，全面查看 Seres Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

39.41M

股息TTM

0.00

市盈率 TTM

-0.05

每股收益TTM

-76.54

营业收入

789.00K

净利润

136.00K

净资产收益率

-121.87%

总资产收益率

-33.29%

Seres Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

120.78%0.47

-102.77%-2.08

8.99%-1.66

-91.95%0.94

47.67%-2.27

1467.03%75.10

71.21%-1.83

255.91%11.63

-159.52%-4.34

51.42%-5.49

42.33%-6.34

---7.46

--7.29

---11.31

---10.99

---35.43

----

营业收入

--736.00K

--358.00K

--438.00K

--351.00K

----

-100.00%0.00

100.00%0.00

-93.44%64.00K

-91.00%310.00K

10300.74%126.47M

-134.96%-522.00K

-86.50%975.00K

-97.28%3.44M

-76.90%1.22M

-73.89%1.49M

-58.89%7.22M

8843.19%126.72M

净利润

123.07%4.58M

-160.93%-19.91M

1.93%-15.34M

-90.76%8.20M

39.60%-19.86M

181.43%32.68M

62.09%-15.64M

285.51%88.78M

-170.61%-32.87M

43.61%-40.13M

40.04%-41.25M

20.25%-47.85M

171.91%46.55M

-25.70%-71.17M

-37.59%-68.80M

-187.96%-60.00M

-33.94%-64.73M

-59.66%-56.62M

-173.95%-50.00M

325.29%68.22M

利润率

--622.42%

---5562.29%

---3501.14%

--2337.32%

----

--36.81%

----

---2947.52%

----

毛利率

--100.00%

----

--100.00%

----

--100.00%

----

资产负债率

----

-100.00%0.00%

28.51%31.86%

57.64%29.89%

93.48%28.32%

--27.50%

--24.79%

--18.96%

--14.64%

--16.31%

----

利润表

营业收入

--736.00K

--358.00K

--438.00K

--351.00K

----

-100.00%0.00

100.00%0.00

-93.44%64.00K

-91.00%310.00K

10300.74%126.47M

-134.96%-522.00K

-86.50%975.00K

-97.28%3.44M

-76.90%1.22M

-73.89%1.49M

-58.89%7.22M

8843.19%126.72M

营业利润

37.84%-15.47M

23.24%-20.91M

36.36%-18.35M

22.94%-22.48M

20.62%-24.88M

10.93%-27.24M

22.12%-28.84M

34.58%-29.17M

-163.29%-31.34M

56.67%-30.58M

-2038.88%-37.02M

24.57%-44.59M

178.21%49.52M

-26.58%-70.57M

96.50%-1.73M

-186.40%-59.11M

-31.54%-63.33M

-57.82%-55.75M

-176.19%-49.43M

328.06%68.41M

净利润

123.07%4.58M

-160.93%-19.91M

1.93%-15.34M

-90.76%8.20M

39.60%-19.86M

181.43%32.68M

62.09%-15.64M

285.51%88.78M

-170.61%-32.87M

43.61%-40.13M

40.04%-41.25M

20.25%-47.85M

171.91%46.55M

-25.70%-71.17M

-37.59%-68.80M

-187.96%-60.00M

-33.94%-64.73M

-59.66%-56.62M

-173.95%-50.00M

325.29%68.22M

资产负债表

流动资产

-13.02%42.35M

-51.82%31.84M

27.67%49.38M

-29.35%51.53M

-67.38%48.69M

-60.00%66.08M

-77.95%38.67M

-65.98%72.93M

-40.59%149.26M

42.30%165.18M

-9.94%175.41M

-13.38%214.39M

19.88%251.24M

-55.90%116.08M

-35.85%194.76M

-31.02%247.51M

-6.67%209.58M

4.47%263.25M

12.97%303.63M

16.49%358.81M

流动负债总额

-35.26%20.03M

-38.24%19.34M

-53.13%19.32M

-65.40%22.43M

-71.43%30.94M

-68.19%31.32M

-58.22%41.22M

-18.17%64.83M

39.00%108.28M

54.31%98.48M

15.26%98.66M

-3.17%79.22M

-12.51%77.90M

-22.51%63.82M

4.06%85.60M

-13.50%81.82M

58.53%89.04M

72.07%82.36M

77.22%82.26M

106.67%94.59M

总资产

-29.35%101.59M

-28.36%117.62M

-1.16%138.19M

-19.73%143.47M

-55.30%143.80M

-51.89%164.18M

-61.01%139.81M

-51.39%178.74M

-20.83%321.73M

26.30%341.26M

2.81%358.60M

17.90%367.70M

48.75%406.39M

-15.54%270.19M

-1.71%348.78M

-21.30%311.87M

1.32%273.20M

4.64%319.89M

3.48%354.86M

11.26%396.29M

总负债

-39.51%67.05M

-19.87%91.12M

-25.43%93.97M

-35.55%99.78M

-72.88%110.85M

-71.64%113.72M

-68.76%126.03M

-59.56%154.82M

6.52%408.81M

26.07%401.00M

19.37%403.46M

56.71%382.82M

53.42%383.77M

33.12%318.06M

51.33%338.00M

10.76%244.28M

48.38%250.14M

47.50%238.93M

32.80%223.35M

31.17%220.56M

总权益

4.81%34.53M

-47.49%26.50M

220.79%44.22M

82.69%43.70M

137.84%32.95M

184.48%50.47M

130.73%13.78M

258.16%23.92M

-485.04%-87.07M

-24.79%-59.74M

-515.99%-44.86M

-122.38%-15.12M

-1.93%22.61M

-159.13%-47.87M

-91.80%10.78M

-61.54%67.58M

-77.19%23.06M

-43.67%80.96M

-24.75%131.51M

-6.55%175.74M

现金流量表

经营净额

-68.52%-22.39M

-160.80%-16.36M

62.17%-14.71M

106.36%2.21M

66.62%-13.29M

176.37%26.91M

18.14%-38.88M

41.47%-34.68M

-160.34%-39.81M

53.99%-35.24M

10.20%-47.50M

0.55%-59.26M

232.24%65.98M

-15.26%-76.58M

-1.99%-52.89M

-146.64%-59.58M

-25.70%-49.90M

-125.27%-66.44M

-189.30%-51.86M

593.86%127.74M

投资净额

107.73%14.00K

100.00%0.00

301.11%181.00K

-100.01%-8.00K

-113.90%-181.00K

45.16%-34.00K

89.74%-90.00K

7954.37%141.14M

-87.62%1.30M

-102.26%-62.00K

-114.80%-877.00K

-104.48%-1.80M

-55.05%10.52M

-78.89%2.74M

-55.06%5.93M

59.81%40.13M

-49.71%23.40M

162.55%12.97M

117.50%13.19M

122.70%25.11M

融资净额

--1.72M

-63.73%428.00K

628.67%12.66M

100.06%61.00K

--0.00

-93.71%1.18M

-72.98%1.74M

-7783.37%-110.87M

-100.00%0.00

231.72%18.76M

39.85%6.43M

-98.53%1.44M

44651.54%58.18M

-78.93%5.66M

689.36%4.60M

15996.39%98.03M

-77.78%130.00K

3414.14%26.85M

-139.29%-780.00K

-99.78%609.00K

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Seres Therapeutics Inc的总收入是多少？



根据Seres Therapeutics Inc的FY2025财报，总收入达到了789.00K（同比变化789.00K）。

Seres Therapeutics Inc的流动资产是多少？



根据Seres Therapeutics Inc的FY2025财报，流动资产为49.38M（同比变化27.67）。

Seres Therapeutics Inc的总资产是多少？



根据Seres Therapeutics Inc的FY2025财报，Seres Therapeutics Inc的总资产为138.19M（同比变化-1.16）。

Seres Therapeutics Inc的总负债是多少？



根据Seres Therapeutics Inc的FY2025财报，Seres Therapeutics Inc的总负债为93.97M（同比变化-25.43）。

Seres Therapeutics Inc的总权益是多少？



根据Seres Therapeutics Inc的FY2025财报，Seres Therapeutics Inc的总权益为44.22M（同比变化220.79）。

Seres Therapeutics Inc的净营业收入是多少？



根据Seres Therapeutics Inc的FY2025财报，Seres Therapeutics Inc的净营业收入为-92.94M（同比变化19.40）。

Seres Therapeutics Inc的净投资是多少？



根据Seres Therapeutics Inc的FY2025财报，Seres Therapeutics Inc的净投资为-42.00K（同比变化-100.03）。

Seres Therapeutics Inc的净融资是多少？



根据Seres Therapeutics Inc的FY2025财报，Seres Therapeutics Inc的净融资为13.90M（同比变化115.38）。

Seres Therapeutics Inc的每股收益（EPS）是多少？



根据Seres Therapeutics Inc的FY2025财报，每股收益（EPS）为0.64（同比变化3553.18）。

Seres Therapeutics Inc的净利润是多少？



根据Seres Therapeutics Inc的FY2025财报，净利润为5.70M（同比变化4088.24）。

Seres Therapeutics Inc的资产回报率（ROA）是多少？



根据Seres Therapeutics Inc的FY2025财报，资产回报率（ROA）为4.10（同比变化108.12）。

Seres Therapeutics Inc的营业利润是多少？



根据Seres Therapeutics Inc的FY2025财报，营业利润为-92.94M（同比变化19.40）。